XARELTO® significantly reduces the risk of stroke in people with AFib‡ notcaused by a heart valve problem.
What is XARELTO®?
XARELTO® belongs to a group of medicines called direct oral anticoagulants, or DOACs† for short. Like other DOACs, XARELTO® has no known dietary restrictions and no requirements for frequent blood tests.
XARELTO® significantly reduces the risk of stroke in people with AFib‡ notcaused by a heart valve problem.
In a clinical trial, over 96% of people who took XARELTO® remained stroke-free.§
XARELTO® offers 24-hour stroke-risk reduction with just one pill a day.*
In a clinical trial comparing XARELTO® to warfarin for reducing the risk of AFib-related stroke, 99% of people taking XARELTO® did not experience bleeding into the brain, which can be serious. However, overall major bleeding was similar and gastrointestinal bleeding was about 1% higher.
*Taken with the evening meal.
†DOACs=direct oral anticoagulants.
‡AFIB=atrial fibrillation
§Rate of first occurrence of stroke was 3.8% for XARELTO® versus 4.3% for warfarin.
Talk to your doctor about XARELTO®
Use this guide to discuss the risks associated with AFib-related stroke with your doctor, and whether XARELTO® may be right for you.
Take one 15-mg or 20-mg tablet
once a day, with dinner
Tablets shown not actual size
How do you take XARELTO®?
Are there any side effects associated with XARELTO® in adults?
Side effects of XARELTO® :
Your risk of bleeding increases if you take XARELTO® with other medicines that also increase your risk of bleeding, such as:
Always tell your healthcare professional if you experience any side effects while taking XARELTO®—keeping an open and honest conversation going with your healthcare professional will help you get the best care. You can use the Doctor Discussion Guide to help inform your conversation.
Getting started with XARELTO®?
Discover information about getting started with XARELTO®, savings options, ongoing support, and your condition—all in one helpful starter kit.